{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T20:12:56Z","timestamp":1789935176929,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR50958\/COT\/142\/54\/2023"],"award-info":[{"award-number":["BT\/PR50958\/COT\/142\/54\/2023"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007674","name":"National Institute of Agricultural Botany","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Anusandhan National Research Foundation","doi-asserted-by":"publisher","award":["CRG\/2022\/004415"],"award-info":[{"award-number":["CRG\/2022\/004415"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.cyto.2026.157200","type":"journal-article","created":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T23:57:47Z","timestamp":1786924667000},"page":"157200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["IFNL1 gene promoter single nucleotide polymorphism rs7247086 enhances transcription through a STAT-binding site"],"prefix":"10.1016","volume":"207","author":[{"given":"Sapana","family":"Kaushik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Bharatiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debarati Guha","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshan","family":"Panchariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahona","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhara","family":"Raval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avik","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Palit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreedhar","family":"Chinnaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cyto.2026.157200_bb0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2026.157200_bb0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2026.157200_bb0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/gene.2016.24","article-title":"Gene-disease association with human IFNL locus polymorphisms extends beyond hepatitis C virus infections","volume":"17","author":"Chinnaswamy","year":"2016","journal-title":"Genes Immun."},{"key":"10.1016\/j.cyto.2026.157200_bb0020","doi-asserted-by":"crossref","unstructured":"Arayasongsak U, Naka I, Ohashi J, Patarapotikul J, Nuchnoi P, Kalambaheti T, Sa-Ngasang A, Chanama S, Chaorattanakawee S. Interferon lambda 1 is associated with dengue severity in Thailand. Int. J. Infect. Dis. 2020 93:121\u2013125. doi:https:\/\/doi.org\/10.1016\/j.ijid.2020.01.026. Epub 2020 Jan 22. PMID: 31981768.","DOI":"10.1016\/j.ijid.2020.01.026"},{"key":"10.1016\/j.cyto.2026.157200_bb0025","doi-asserted-by":"crossref","unstructured":"Galimova E, Akhmetova V, Latipov B, Kingo K, R\u00e4tsep R, Traks T, K\u00f5ks S, Khusnutdinova E. Analysis of genetic variants of class II cytokine and their receptor genes in psoriasis patients of two ethnic groups from the Volga-Ural region of Russia. J. Dermatol. Sci. 2012 68(1):9\u201318. doi:https:\/\/doi.org\/10.1016\/j.jdermsci.2012.07.002. Epub 2012 Jul 16. PMID: 22840887.","DOI":"10.1016\/j.jdermsci.2012.07.002"},{"key":"10.1016\/j.cyto.2026.157200_bb0030","doi-asserted-by":"crossref","unstructured":"Hammad MO, Alseoudy MM, Borg AM, El-Mesery A, Elgamal M, Abdelghany DA, Elzeiny D. IFNL1 rs30461 polymorphism as a risk factor for COVID-19 severity: a cross-sectional study. Cytokine 2024 176:156500. doi:https:\/\/doi.org\/10.1016\/j.cyto.2024.156500. Epub 2024 Jan 24. PMID: 38271827.","DOI":"10.1016\/j.cyto.2024.156500"},{"issue":"3","key":"10.1016\/j.cyto.2026.157200_bb0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/jir.1997.17.121","article-title":"GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression","volume":"17","author":"Decker","year":"1997","journal-title":"J. Interferon Cytokine Res."},{"issue":"15","key":"10.1016\/j.cyto.2026.157200_bb0040","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/nar\/22.15.3033","article-title":"In vivo footprinting of the IRF-1 promoter: inducible occupation of a GAS element next to a persistent structural alteration of the DNA","volume":"22","author":"Rein","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cyto.2026.157200_bb0045","doi-asserted-by":"crossref","unstructured":"Roy DG, Singh L, Chaturvedi HK, Chinnaswamy S. Gender-dependent multiple cross-phenotype association of interferon lambda genetic variants with peripheral blood profiles in healthy individuals. Mol. Genet. Genomic Med. 2024a 12(1): e2292. (PMID: 37795763; PMCID: PMC10767428).","DOI":"10.1002\/mgg3.2292"},{"key":"10.1016\/j.cyto.2026.157200_bb0050","series-title":"RStudio: Integrated Development Environment for R","author":"RStudio Team","year":"2021"},{"key":"10.1016\/j.cyto.2026.157200_bb0055","doi-asserted-by":"crossref","unstructured":"Roy DG, De M, Bharatiya S, Khedekar DA, Datta K, Bhattacharjee S, Chinnaswamy S. Evidence for a sex-dependent effect modification in the association between IFN-\u03bb DNA polymorphisms and expression of IFN-\u03bb and interferon-stimulated genes in human PBMCs. Cytokine 2024b 184:156779. doi:https:\/\/doi.org\/10.1016\/j.cyto.2024.156779. Epub 2024 Oct 17. PMID: 39423653.","DOI":"10.1016\/j.cyto.2024.156779"},{"issue":"7422","key":"10.1016\/j.cyto.2026.157200_bb0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature11632","article-title":"An integrated map of genetic variation from 1,092 human genomes","volume":"491","author":"1000 Genomes Project Consortium","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2026.157200_bb0065","doi-asserted-by":"crossref","unstructured":"Chinnaswamy S, Bhushan A, Behera AK, Ghosh S, Rampurkar V, Chandra V, Pandit B, Kundu TK. Roles for transcription factors Sp1, NF-\u03baB, IRF3, and IRF7 in expression of the human IFNL4 gene. Viral Immunol. 2016 Jan-29(1):49-63. doi:https:\/\/doi.org\/10.1089\/vim.2015.0076. (Epub 2015 Dec 18. PMID: 26684959).","DOI":"10.1089\/vim.2015.0076"},{"key":"10.1016\/j.cyto.2026.157200_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155491","article-title":"Functional genetic variants of the IFN-\u03bb3 (IL28B) gene and transcription factor interactions on its promoter","volume":"142","author":"Roy","year":"2021","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.cyto.2026.157200_bb0075","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/bioinformatics\/18.2.333","article-title":"PROMO: detection of known transcription regulatory elements using species-tailored searches","volume":"18","author":"Messeguer","year":"2002","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cyto.2026.157200_bb0080","doi-asserted-by":"crossref","unstructured":"Li YJ, Zhang C, Martincuks A, Herrmann A, Yu H. STAT proteins in cancer: orchestration of metabolism. Nat. Rev. Cancer 2023 23(3):115\u2013134. doi:https:\/\/doi.org\/10.1038\/s41568-022-00537-3. Epub 2023 Jan 3. PMID: 36596870.","DOI":"10.1038\/s41568-022-00537-3"},{"issue":"9","key":"10.1016\/j.cyto.2026.157200_bb0085","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1074\/jbc.M001748200","article-title":"DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites","volume":"276","author":"Ehret","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.cyto.2026.157200_bb0090","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","article-title":"The JAK-STAT pathway at 30: much learned, much more to do","volume":"185","author":"Philips","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2026.157200_bb0095","doi-asserted-by":"crossref","unstructured":"Cheon H, Stark GR. Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes. Proc. Natl. Acad. Sci. U. S. A. 2009 Jun 9;106(23):9373\u20138. doi:https:\/\/doi.org\/10.1073\/pnas.0903487106. Epub 2009 May 28. PMID: 19478064; PMCID: PMC2688000.","DOI":"10.1073\/pnas.0903487106"},{"key":"10.1016\/j.cyto.2026.157200_bb0100","doi-asserted-by":"crossref","unstructured":"Nkansah E, Shah R, Collie GW, Parkinson GN, Palmer J, Rahman KM, Bui TT, Drake AF, Husby J, Neidle S, Zinzalla G, Thurston DE, Wilderspin AF. Observation of unphosphorylated STAT3 core protein binding to target dsDNA by PEMSA and X-ray crystallography. FEBS Lett. 2013 587(7):833\u20139. doi:https:\/\/doi.org\/10.1016\/j.febslet.2013.01.065. Epub 2013 Feb 19. PMID: 23434585.","DOI":"10.1016\/j.febslet.2013.01.065"},{"issue":"17","key":"10.1016\/j.cyto.2026.157200_bb0105","doi-asserted-by":"crossref","first-page":"14192","DOI":"10.1074\/jbc.M111.323899","article-title":"Mechanisms of unphosphorylated STAT3 transcription factor binding to DNA","volume":"287","author":"Timofeeva","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2026.157200_bb0110","doi-asserted-by":"crossref","unstructured":"Yilmaz B, \u00c7akmak Gen\u00e7 G, Karaka\u015f \u00c7elik S, Solak Tekin N, Can M, Dursun A. Association between psoriasis disease and IFN-\u03bb gene polymorphisms. Immunol. Invest. 2022 51(6):1772\u20131784. doi:https:\/\/doi.org\/10.1080\/08820139.2022.2036187. Epub 2022 Feb 4. PMID: 35118914.","DOI":"10.1080\/08820139.2022.2036187"},{"key":"10.1016\/j.cyto.2026.157200_bb0115","doi-asserted-by":"crossref","unstructured":"Dogra S, Yadav S. Psoriasis in India: prevalence and pattern. Indian J. Dermatol. Venereol. Leprol. 2010 Nov-76(6):595-601. doi:https:\/\/doi.org\/10.4103\/0378-6323.72443. (PMID: 21079301).","DOI":"10.4103\/0378-6323.72443"},{"key":"10.1016\/j.cyto.2026.157200_bb0120","doi-asserted-by":"crossref","unstructured":"Prokunina-Olsson L. Genetics of the human interferon lambda region. J. Interferon Cytokine Res. 2019 39(10):599\u2013608. doi:https:\/\/doi.org\/10.1089\/jir.2019.0043. Epub 2019 May 8. PMID: 31070498; PMCID: PMC6767866.","DOI":"10.1089\/jir.2019.0043"},{"key":"10.1016\/j.cyto.2026.157200_bb0125","doi-asserted-by":"crossref","unstructured":"Arpaci D, Karakas Celik S, Can M, Cakmak Genc G, Kuzu F, Unal M, Bayraktaroglu T. Increased serum levels of IL-28 and IL-29 and the protective effect of IL28B rs8099917 polymorphism in patients with Hashimoto's thyroiditis. Immunol. Invest. 2016 45(7):668\u201378. doi:https:\/\/doi.org\/10.1080\/08820139.2016.1208215. Epub 2016 Sep 12. PMID: 27617784.","DOI":"10.1080\/08820139.2016.1208215"},{"key":"10.1016\/j.cyto.2026.157200_bb0130","doi-asserted-by":"crossref","unstructured":"Cakmak Genc G, Dursun A, Karakas Celik S, Calik M, Kokturk F, Piskin IE. IL28B, IL29 and micro-RNA 548 in subacute sclerosing panencephalitis as a rare disease. Gene 2018 Dec 15;678:73\u201378. doi:https:\/\/doi.org\/10.1016\/j.gene.2018.07.062. Epub 2018 Aug 2. PMID: 30077763.","DOI":"10.1016\/j.gene.2018.07.062"},{"key":"10.1016\/j.cyto.2026.157200_bb0135","doi-asserted-by":"crossref","unstructured":"Shivaprasad BM, Pradeep AR. Correlation of the interleukin-29 levels in crevicular fluid and plasma with the genetic polymorphism in chronic and aggressive periodontitis patients. Arch. Oral Biol. 2015 60(1):37\u201344. doi:https:\/\/doi.org\/10.1016\/j.archoralbio.2014.08.017. Epub 2014 Sep 16. PMID: 25255471.","DOI":"10.1016\/j.archoralbio.2014.08.017"},{"key":"10.1016\/j.cyto.2026.157200_bb0140","doi-asserted-by":"crossref","unstructured":"Woods E, Mena A, Sierpinska S, Carr E, Sttar Bioresource, Hagan R, Crowley J, Bergin C, Clark D, Brophy C, Macallan D, Gardiner CM. Reduced IFNL1 and\/or IFNL2, but not IFNL3 is associated with worse outcome in patients with COVID-19. Clin. Exp. Immunol. 2024 Nov 12;218(3):300\u2013307. doi:https:\/\/doi.org\/10.1093\/cei\/uxae047. (PMID: 38953458; PMCID: PMC11557148).","DOI":"10.1093\/cei\/uxae047"},{"key":"10.1016\/j.cyto.2026.157200_bb0145","doi-asserted-by":"crossref","unstructured":"Sposito B, Broggi A, Pandolfi L, Crotta S, Clementi N, Ferrarese R, Sisti S, Criscuolo E, Spreafico R, Long JM, Ambrosi A, Liu E, Frangipane V, Saracino L, Bozzini S, Marongiu L, Facchini FA, Bottazzi A, Fossali T, Colombo R, Clementi M, Tagliabue E, Chou J, Pontiroli AE, Meloni F, Wack A, Mancini N, Zanoni I. The interferon landscape along the respiratory tract impacts the severity of COVID-19. Cell 2021 Sep 16;184(19):4953\u20134968.e16. doi:https:\/\/doi.org\/10.1016\/j.cell.2021.08.016. Epub 2021 Aug 19. PMID: 34492226; PMCID: PMC8373821.","DOI":"10.1016\/j.cell.2021.08.016"},{"key":"10.1016\/j.cyto.2026.157200_bb0150","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S2213-2600(20)30566-X","article-title":"Peginterferon lambda for the treatment of out patients with COVID-19: a phase 2, placebo-controlled randomised trial","volume":"9","author":"Feld","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.cyto.2026.157200_bb0155","doi-asserted-by":"crossref","unstructured":"Reis G, Moreira Silva EAS, Medeiros Silva DC, Thabane L, Campos VHS, Ferreira TS, Santos CVQ, Nogueira AMR, Almeida APFG, Savassi LCM, Figueiredo-Neto AD, Dias ACF, Freire J\u00fanior AM, Bitar\u00e3es C, Milagres AC, Callegari ED, Simplicio MIC, Ribeiro LB, Oliveira R, Harari O, Wilson LA, Forrest JI, Ruton H, Sprague S, McKay P, Guo CM, Limbrick-Oldfield EH, Kanters S, Guyatt GH, Rayner CR, Kandel C, Biondi MJ, Kozak R, Hansen B, Zahoor MA, Arora P, Hislop C, Choong I, Feld JJ, Mills EJ, Glenn JS; TOGETHER Investigators. Early treatment with pegylated interferon lambda for Covid-19. N. Engl. J. Med. 2023 Feb 9;388(6):518\u2013528. doi:https:\/\/doi.org\/10.1056\/NEJMoa2209760. PMID: 36780676; PMCID: PMC9933926.","DOI":"10.1056\/NEJMoa2209760"},{"key":"10.1016\/j.cyto.2026.157200_bb0160","doi-asserted-by":"crossref","unstructured":"Santer DM, Li D, Ghosheh Y, Zahoor MA, Prajapati D, Hansen BE, Tyrrell DLJ, Feld JJ, Gehring AJ. Interferon-\u03bb treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity. Nat. Commun. 2022 6;13(1):6992. doi:10.1038\/s41467-022-34709-4. PMID: 36385011; PMCID: PMC9667439.","DOI":"10.1038\/s41467-022-34709-4"},{"key":"10.1016\/j.cyto.2026.157200_bb0165","doi-asserted-by":"crossref","unstructured":"M\u00f8hlenberg M, Gad HH, Hartmann R. The influence of the rs30461 single nucleotide polymorphism on IFN-\u03bb1 activity and secretion. J. Interferon Cytokine Res. 2019 39(10):661\u2013667. doi:https:\/\/doi.org\/10.1089\/jir.2019.0051. Epub 2019 May 22. PMID: 31120365.","DOI":"10.1089\/jir.2019.0051"},{"key":"10.1016\/j.cyto.2026.157200_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.833636","article-title":"High interferon signature leads to increased STAT1\/3\/5 phosphorylation in PBMCs from SLE patients by single cell mass cytometry","volume":"13","author":"Yiu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2026.157200_bb0175","doi-asserted-by":"crossref","unstructured":"Gu H, Zhang Y, Zeng W, Xia Y. Participation of interferons in psoriatic inflammation. Cytokine Growth Factor Rev. 2022 64:12\u201320. doi:https:\/\/doi.org\/10.1016\/j.cytogfr.2021.12.002. Epub 2021 Dec 13. PMID: 34953718.","DOI":"10.1016\/j.cytogfr.2021.12.002"},{"key":"10.1016\/j.cyto.2026.157200_bb0180","doi-asserted-by":"crossref","unstructured":"Fu LX, Chen T, Guo ZP, Cao N, Zhang LW, Zhou PM. Enhanced serum interferon-lambda 1 interleukin-29 levels in patients with psoriasis vulgaris. An. Bras. Dermatol. 2021 96(4):416\u2013421. doi:https:\/\/doi.org\/10.1016\/j.abd.2020.11.007. Epub 2021 May 24. PMID: 34030913; PMCID: PMC8245709.","DOI":"10.1016\/j.abd.2020.11.007"},{"key":"10.1016\/j.cyto.2026.157200_bb0185","doi-asserted-by":"crossref","unstructured":"Wolk K, Witte K, Witte E, Raftery M, Kokolakis G, Philipp S, Sch\u00f6nrich G, Warszawska K, Kirsch S, Pr\u00f6sch S, Sterry W, Volk HD, Sabat R. IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis. Sci. Transl. Med. 2013;5(204):204ra129. doi:https:\/\/doi.org\/10.1126\/scitranslmed.3006245. (PMID: 24068736).","DOI":"10.1126\/scitranslmed.3006245"}],"updated-by":[{"DOI":"10.1016\/j.cyto.2026.157208","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000}},{"DOI":"10.1016\/j.cyto.2026.157208","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000}}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T19:56:33Z","timestamp":1789934193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466626000955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":37,"alternative-id":["S1043466626000955"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157200","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IFNL1 gene promoter single nucleotide polymorphism rs7247086 enhances transcription through a STAT-binding site","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157200"}}